Through partnerships with big tech or developments of smart implants, the orthopaedic companies are exploring how utilizing data can improve procedures and patient outcomes.
Amid progress by robotic surgery companies in ramping up system placements and procedures, orthopaedic market leaders like Stryker and Zimmer Biomet say better utilizing patient data is the next step.
Patient data has piled up amid volume taking off over the past several years. The information collected before and after operations, as well as information collected by the robots during surgery, has become increasingly valuable as companies look to improve patient outcomes and fine-tune their systems.
“The big future potential is on the data analytics,” Robert Cohen, president of digital, robotics and enabling technologies for Stryker, said. “We’re going big on data science and data analytics.”
Stryker has become a leader in the orthopaedic robotic market with its Mako system, which can be used for total and partial knee replacements and total hip replacements.
Cohen said that surgeons using Mako can learn from past procedures by looking at metrics like the accuracy of implant positioning. Data of past procedures can also help identify which implants may work better for a specific patient.
Benjamin Domb, founder and medical director of the American Hip Institute, a clinic specializing in hip treatments and surgeries, said that having access to this patient-specific information has improved the quality of robotic procedures.
By Ricky Zipp | HealthcareDive
Image Credit: Wikimedia Commons
Be the first to comment